Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0TQLIL
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
Anti-CD8-idarubicin conjugate
|
|||||
| Synonyms |
Anti-Ly2.1-idarubicin conjugate; Anti CD8 idarubicin conjugate
Click to Show/Hide
|
|||||
| Drug Status |
Clinical candidate
|
|||||
| Indication |
In total 1 Indication(s)
Graft-versus-host disease [ICD11:4B24]
Clinical candidate
|
|||||
| Antibody Name |
Anti-CD8 (Ly-2.1) mAb
|
Antibody Info | ||||
| Antigen Name |
T-cell surface glycoprotein CD8 alpha chain (CD8A); T-cell surface glycoprotein CD8 alpha chain (CD8A)
|
Antigen Info | ||||
| Payload Name |
Idarubicin
|
Payload Info | ||||
| Therapeutic Target |
DNA topoisomerase 2-alpha (TOP2A)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.